Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Xgeva Market Report 2025

Xgeva Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Formulation (60 Mg Injection, 120 Mg Injection), By Indication (Bone Metastases, Giant Cell Tumor of Bone (GCTB), Hypercalcemia of Malignancy), By End User (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Xgeva Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Xgeva Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Xgeva Market Definition

Xgeva (denosumab) refers to a monoclonal antibody used in the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors and in the treatment of giant cell tumors of bone and osteoporosis in high-risk patients. It is utilized through subcutaneous injections administered by a healthcare professional.

The main types of formulations in xgeva include 60 mg injection and 120 mg injection. Xgeva formulation with a dosage of 60 mg, typically administered as a single injection to address specific patient needs based on prescribed treatment regimens, focusing on conditions requiring lower dosages. The indications include bone metastases, giant cell tumor of bone (GCTB), and hypercalcemia of malignancy for end users such as hospitals, homecare, specialty clinics, and ambulatory surgical centers. The distribution channels include hospitals, retail pharmacies, and online pharmacies.

Xgeva Market Segmentation

The xgeva market covered in this report is segmented –

1) By Formulation: 60 Mg Injection; 120 Mg Injection

2) By Indication: Bone Metastases; Giant Cell Tumor of Bone (GCTB); Hypercalcemia of Malignancy

3) By End User: Hospitals; Homecare; Specialty Clinics; Ambulatory Surgical Centers

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Xgeva Market Size and growth rate 2025 to 2029: Graph

Xgeva Market Size 2025 And Growth Rate

The xgeva market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing cancer prevalence, rising awareness of bone metastases, growing geriatric population, increasing healthcare expenditure, improved regulatory approvals, growing investment in oncology research, and rising prevalence of skeletal-related events.

Xgeva Market Growth Forecast

The xgeva market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing incidence of bone-related metastases in cancer patients, growing adoption of Xgeva in cancer treatment regimens, rising awareness of the drug's benefits, and growing aging population. Major trends in the forecast period include expanding indications for bone-related cancers, innovations in treatment delivery methods, and advancements in personalized medicine.

Book your 30 minutes free consultation with our research experts

Contact Us

Xgeva Market Driver: Increasing Prevalence Of Bone Metastasis Boosts Market

The increasing prevalence of bone metastasis is propelling the growth of the xgeva market. Bone metastasis refers to the spread of cancer cells from their original site to the bones, often causing pain, fractures, and a range of other complications. The increase in prevalence of bone metastasis is due to the rising global incidence of cancers, particularly breast, prostate, and lung cancers, which are more likely to metastasize to the bones. As the prevalence of bone metastasis increases, the demand for effective treatments to manage bone-related complications also grows, positioning xgeva as a critical therapeutic option for preventing fractures and improving patient outcomes in individuals affected by metastatic bone disease. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of bone and joint metastatic cancer cases increased to 3,970 compared to 3,910 in 2022, reflecting a growth of 1.5%. Therefore, the increasing prevalence of bone metastasis is expected to drive the growth of the xgeva market.

Global Xgeva Market Major Players

Major companies operating in the xgeva market are Amgen Inc.

Global Xgeva Market Trend: New Formulation Enhances Patient Access And Convenience

The key trend in the xgeva market is focusing on expanding their product offerings, enhancing formulations such as prefilled syringes, and improving patient access to treatment. A prefilled syringe refers to a single-dose, ready-to-use syringe preloaded with medication, designed to simplify administration, improve dosing accuracy, and enhance patient convenience. For instance, in March 2024, the Medicines and Healthcare Products Regulatory Agency, a UK-based government agency responsible for regulating medicines, approved a new high-concentration formulation of Amgen's Xgeva (denosumab) as a 120 mg solution for injection in a prefilled syringe. This approval, granted under the new International Recognition Procedure (IRP), enables UK patients to access a more convenient and streamlined treatment option. Furthermore, this move enhances patient experience by simplifying the administration process, reducing the volume of liquid injected, and lowering the risk of dosing errors.

Xgeva Market Merger And Acquisition: Alvotech And Dr. Reddy’s Collaboration Accelerates Commercialization Of AVT03 (Denosumab)

In May 2024, Alvotech, a Luxembourg-based company specializing in the development and manufacture of biosimilar medicines, collaborated with Dr. Reddy’s Laboratories SA. to accelerate the commercialization of AVT03 (denosumab), a biosimilar candidate to Xgeva, by leveraging Dr. Reddy’s established presence in the U.S., Europe, and the UK, ensuring broader access to affordable treatment options for patients with conditions such as osteoporosis and bone-related complications from cancer. Dr. Reddy’s Laboratories SA is an India-based global pharmaceutical company involved in the development and manufacture of medicines.

Regional Analysis For The Global Xgeva Market

North America was the largest region in the xgeva market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xgeva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the xgeva market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Xgeva Market?

The xgeva market consists of sales of prefilled syringes and vials. Values in this market are ‘factory gate’ values, representing the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Xgeva Industry?

The xgeva market research report is one of a series of new reports from The Business Research Company that provides xgeva market statistics, including xgeva industry global market size, regional shares, competitors with a xgeva market share, detailed xgeva market segments, market trends and opportunities, and any further data you may need to thrive in the xgeva industry. This xgeva market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Xgeva Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The xgeva market covered in this report is segmented –
1) By Formulation: 60 Mg Injection; 120 Mg Injection
2) By Indication: Bone Metastases; Giant Cell Tumor of Bone (GCTB); Hypercalcemia of Malignancy
3) By End User: Hospitals; Homecare; Specialty Clinics; Ambulatory Surgical Centers
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Amgen Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Xgeva Market Characteristics

    3. Xgeva Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Xgeva Market Trends And Strategies

    5. Xgeva Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Xgeva Growth Analysis And Strategic Analysis Framework

    6.1. Global Xgeva PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Xgeva Market Growth Rate Analysis

    6.4. Global Xgeva Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Xgeva Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Xgeva Total Addressable Market (TAM)

    7. Global Xgeva Pricing Analysis & Forecasts

    8. Xgeva Market Segmentation

    8.1. Global Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    60 Mg Injection

    120 Mg Injection

    8.2. Global Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Bone Metastases

    Giant Cell Tumor of Bone (GCTB)

    Hypercalcemia of Malignancy

    8.3. Global Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Homecare

    Specialty Clinics

    Ambulatory Surgical Centers

    8.4. Global Xgeva Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    9. Global Xgeva Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Xgeva Market Regional And Country Analysis

    10.1. Global Xgeva Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Xgeva Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Xgeva Market

    11.1. Asia-Pacific Xgeva Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Xgeva Market

    12.1. China Xgeva Market Overview

    12.2. China Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Xgeva Market

    13.1. India Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Xgeva Market

    14.1. Japan Xgeva Market Overview

    14.2. Japan Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Xgeva Market

    15.1. Australia Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Xgeva Market

    16.1. South Korea Xgeva Market Overview

    16.2. South Korea Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Xgeva Market

    17.1. Western Europe Xgeva Market Overview

    17.2. Western Europe Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Xgeva Market

    18.1. UK Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Xgeva Market

    19.1. Germany Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Xgeva Market

    20.1. France Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Xgeva Market

    21.1. Eastern Europe Xgeva Market Overview

    21.2. Eastern Europe Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Xgeva Market

    22.1. North America Xgeva Market Overview

    22.2. North America Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Xgeva Market

    23.1. USA Xgeva Market Overview

    23.2. USA Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Xgeva Market

    24.1. Canada Xgeva Market Overview

    24.2. Canada Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Xgeva Market

    25.1. South America Xgeva Market Overview

    25.2. South America Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Xgeva Market

    26.1. Middle East Xgeva Market Overview

    26.2. Middle East Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Xgeva Market

    27.1. Africa Xgeva Market Overview

    27.2. Africa Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Xgeva Market Competitive Landscape And Company Profiles

    28.1. Xgeva Market Competitive Landscape

    28.2. Xgeva Market Company Profiles

    28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Xgeva Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Xgeva Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Xgeva Market

    32. Recent Developments In The Xgeva Market

    33. Xgeva Market High Potential Countries, Segments and Strategies

    33.1 Xgeva Market In 2029 - Countries Offering Most New Opportunities

    33.2 Xgeva Market In 2029 - Segments Offering Most New Opportunities

    33.3 Xgeva Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Xgeva Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Xgeva Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Xgeva Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: Amgen Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Xgeva Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Xgeva Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Xgeva Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Xgeva Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Xgeva Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Xgeva Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: Amgen Inc. Financial Performance

Global Protein Purification And Isolation Market 2022 – Market Opportunities And Strategies

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Brain Tumor Drugs Global Market Report 2025 – By Drugs (Temozolomide, Bevacizumab, Other Drugs), By End User (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Ablation Therapy Devices Global Market Report 2025 – By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies), By Treatment (Surgical, Laparoscopic, Percutaneous), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications), By End User (Hospitals, Oncology Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Embolization Devices Global Market Report 2025 – By Type (Radioembolic Agents, Non-radioactive Embolic Agents), By Application (Cancer Tumors, Noncancerous Tumors), By End User (Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Tumor Profiling Global Market Report 2025 – By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Other Cancer Types ), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Microarray, Other Technologies), By Process Type (Genomics, Proteomics, Epigenetics, Metabolomics, Other Types), By Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, Research Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Circulating Tumor Cells Global Market Report 2025 – By Product (Kits And Reagents, Blood Collection Tubes, Devices Or Systems), By Technology (CTC Enrichment, CTC Detection, CTC Analysis), By Specimen (Blood, Bone Marrow, Other Body Fluids), By Application (Clinical Or Liquid Biopsy, Research) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2025 – By Product Type (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars ), By Route Of Administration (Subcutaneous Injection, Intravenous Injection ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies ), By Application (Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Crohn’s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Tumor Infiltrating Lymphocytes Global Market Report 2025 – By Anatomy (CD3, CD8, CD16, CD56, CD4, CD57, CD169, CD68, FOXP3), By Component (T-Cells, B-Cells, Natural Killer Cells), By Application (Melanoma, Cervical Cancer, Ovarian Cancer, Other Applications), By End-User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Brain Tumor Drugs Market 2022 - By Drugs (Temozolomide, Bevacizumab), By End User (Hospital Pharmacies, Retail Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Xgeva market?

Xgeva (denosumab) refers to a monoclonal antibody used in the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors and in the treatment of giant cell tumors of bone and osteoporosis in high-risk patients. It is utilized through subcutaneous injections administered by a healthcare professional. For further insights on the Xgeva market, request a sample here

How will the Xgeva market drivers and restraints affect the market dynamics? What forces will shape the Xgeva industry going forward?

The Xgeva market major growth driver - Increasing Prevalence Of Bone Metastasis Boosts Market. For further insights on the Xgeva market, request a sample here

What is the forecast market size or the forecast market value of the Xgeva market?

The Xgeva market size has grown strongly in recent years. The xgeva market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing cancer prevalence, rising awareness of bone metastases, growing geriatric population, increasing healthcare expenditure, improved regulatory approvals, growing investment in oncology research, and rising prevalence of skeletal-related events. The xgeva market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing incidence of bone-related metastases in cancer patients, growing adoption of Xgeva in cancer treatment regimens, rising awareness of the drug's benefits, and growing aging population. Major trends in the forecast period include expanding indications for bone-related cancers, innovations in treatment delivery methods, and advancements in personalized medicine. For further insights on the Xgeva market, request a sample here

How is the Xgeva market segmented?

The xgeva market covered in this report is segmented –
1) By Formulation: 60 Mg Injection; 120 Mg Injection
2) By Indication: Bone Metastases; Giant Cell Tumor of Bone (GCTB); Hypercalcemia of Malignancy
3) By End User: Hospitals; Homecare; Specialty Clinics; Ambulatory Surgical Centers
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies For further insights on the Xgeva market, request a sample here

Which region has the largest share of the Xgeva market? What are the other regions covered in the report?

North America was the largest region in the xgeva market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xgeva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Xgeva market, request a sample here.

Who are the major players in the Xgeva market?

Major companies operating in the xgeva market are Amgen Inc. . For further insights on the Xgeva market, request a sample here.

What are the key trends in the Xgeva market?

Major trends in the Xgeva market include New Formulation Enhances Patient Access And Convenience. For further insights on the Xgeva market, request a sample here.

What are the major opportunities in the Xgeva market? What are the strategies for the Xgeva market?

For detailed insights on the major opportunities and strategies in the Xgeva market, request a sample here.

How does the Xgeva market relate to the overall economy and other similar markets?

For detailed insights on Xgeva's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Xgeva industry?

For detailed insights on the mergers and acquisitions in the Xgeva industry, request a sample here.

What are the key dynamics influencing the Xgeva market growth? SWOT analysis of the Xgeva market.

For detailed insights on the key dynamics influencing the Xgeva market growth and SWOT analysis of the Xgeva industry, request a sample here.